Fatty liver disease (MASLD/MASH) trials in China

In China 73 Also abroad 368

73 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseEnrolling by invitation
Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia
Where
Ningbo
Age
18 years to 100 years
People
17,040
Run by
Ningbo No. 1 Hospital
See details and how to joinNCT07001865
Phase 2Taking people
Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improving Metabolic Associated Fatty Liver Disease : a Randomized Clinical Trial
Where
Hangzhou
Age
18 years to 65 years
People
100
Run by
Li Lab,MD
See details and how to joinNCT06798948
No phaseTaking people
An Observational Study of Inflammatory Bowel Disease (IBD) Patients With Non-alcoholic Fatty Liver Disease (NAFLD)
Where
Shanghai
Age
18 years and over
People
337
Run by
Shanghai East Hospital
See details and how to joinNCT06939569
No phaseTaking people
Effect of Low Valine Diet on Body Weight and Metabolic Parameters
Where
Shanghai
Age
16 years to 80 years
People
48
Run by
Shanghai Zhongshan Hospital
See details and how to joinNCT06883578
No phaseTaking people
Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study
Where
Chongqing
Age
18 years to 90 years
People
7,000
Run by
Chongqing Medical University
See details and how to joinNCT05974904
No phaseNot yet taking people in China
Clinical Classification of MAFLD Based Liver Biopsy
Where
Beijing, Hangzhou, Shanghai, Tianjin
People
2,000
Run by
Beijing Friendship Hospital
See details and how to joinNCT06795646
No phaseTaking people
LivQ-box® Parameters in the Diagnosis of Liver Inflammation
Where
Beijing
Age
18 years and over
People
365
Run by
Wuxi Hisky Medical Technology Co Ltd
See details and how to joinNCT06802731
No phaseNot yet taking people in China
The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis
Where
Beijing
Age
18 years to 75 years
People
195
Run by
Beijing Friendship Hospital
See details and how to joinNCT06773221
Phase 4Not yet taking people in China
Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM
Where
Nanjing
Age
18 years to 75 years
People
190
Run by
Xiqiao Zhou
See details and how to joinNCT06762223
No phaseTaking people
Feasibility Study of Deep Learning-based MDixon Quant for Quantitative Assessment of Chemotherapy-induced Fatty Liver
Where
Kunming
Age
18 years to 80 years
People
120
Run by
Yunnan Cancer Hospital
See details and how to joinNCT06735118
No phaseTaking people
The Effects of Tai Chi on Metabolic Dysfunction-associated Fatty Liver Disease in Middle-Aged and Older Adults
Where
Fuzhou
Age
40 years to 75 years
People
250
Run by
Fujian Provincial Hospital
See details and how to joinNCT06717828
No phaseTaking people
Establishment of Precise Histological Evaluation Criteria for NASH Fibrosis Reversal
Where
Beijing
Age
18 years to 70 years
People
50
Run by
Beijing Municipal Administration of Hospitals
See details and how to joinNCT06707129
Phase 2Taking people
Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH)
Where
Baoding, Beijing, Cangzhou, Changchun, Changsha, Chifeng, Fuzhou, Ganzhou, Hangzhou, Jiangyin, Leshan, Liaocheng, Liuzhou, Lu'an, Luoyang, Luzhou, Meishan, Mianyang, Nanjing, Ningbo, Puer, Puyang, Qingyuan, Shanghai, Shenyang, Shenzhen, Shijiazhuang, Taiyuan, Tianjin, Wuhan, Wuwei, Wuxi, Xiamen, Xi’an, Xuzhou, Yiwu, Yueyang, Yulin, Zhengzhou, Zhenjiang, Zhoukou, Zhoushan, Zigong
Age
18 years to 75 years
People
120
Run by
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
See details and how to joinNCT06569524
Phase 4Taking people
Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD
Where
Guangzhou
Age
18 years to 75 years
People
100
Run by
Zhujiang Hospital
See details and how to joinNCT06449833
No phaseTaking people
Effectiveness of Bariatric Surgery for NAFLD/NASH
Where
Beijing
Age
16 years to 65 years
People
320
Run by
Beijing Friendship Hospital
See details and how to joinNCT04366999
Phase 4Taking people
Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）
Where
Ningbo, Rui’an, Wenzhou, Yueqing
Age
18 years to 60 years
People
1,500
Run by
First Affiliated Hospital of Wenzhou Medical University
See details and how to joinNCT06368882
No phaseTaking people
Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)
Where
Shanghai
Age
18 years to 75 years
People
20,000
Run by
Ruijin Hospital
See details and how to joinNCT05870969
No phaseTaking people
Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD
Where
Nanjing
Age
18 years and over
People
1,000
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT05766449
No phaseTaking people
Observational Study About Patients Diagnosed With NAFLD
Where
Changsha
Age
18 years to 75 years
People
500
Run by
Xiangya Hospital of Central South University
See details and how to joinNCT05625750
No phaseTaking people
Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China
Where
Nanjing
Age
18 years and over
People
2,900
Run by
Wuxi Hisky Medical Technology Co Ltd
See details and how to joinNCT05597709
No phaseTaking people
BeijngFH Health Cohort Study
Where
Beijing
Age
18 years and over
People
8,103
Run by
Beijing Friendship Hospital
See details and how to joinNCT05546086
No phaseTaking people
A Prospective/Retrospective, Observational Follow-up Study of Chronic Hepatitis B With Non-alcoholic Fatty Liver Disease.
Where
Wuhan
Age
18 years and over
People
10,000
Run by
Qin Ning
See details and how to joinNCT05255978
No phaseTaking people
A Prospective Cohort Study of Metabolic Associated Fatty Liver Disease in China
Where
Guangzhou
Age
18 years to 80 years
People
3,000
Run by
Nanfang Hospital, Southern Medical University
See details and how to joinNCT04573283